| Literature DB >> 28603672 |
Abstract
The changes of protein expression that are monitored in proteomic experiments are a type of biological transformation that also involves changes in chemical composition. Accompanying the myriad molecular-level interactions that underlie any proteomic transformation, there is an overall thermodynamic potential that is sensitive to microenvironmental conditions, including local oxidation and hydration potential. Here, up- and down-expressed proteins identified in 71 comparative proteomics studies were analyzed using the average oxidation state of carbon (ZC) and water demand per residue ([Formula: see text]), calculated using elemental abundances and stoichiometric reactions to form proteins from basis species. Experimental lowering of oxygen availability (hypoxia) or water activity (hyperosmotic stress) generally results in decreased ZC or [Formula: see text] of up-expressed compared to down-expressed proteins. This correspondence of chemical composition with experimental conditions provides evidence for attraction of the proteomes to a low-energy state. An opposite compositional change, toward higher average oxidation or hydration state, is found for proteomic transformations in colorectal and pancreatic cancer, and in two experiments for adipose-derived stem cells. Calculations of chemical affinity were used to estimate the thermodynamic potentials for proteomic transformations as a function of fugacity of O2 and activity of H2O, which serve as scales of oxidation and hydration potential. Diagrams summarizing the relative potential for formation of up- and down-expressed proteins have predicted equipotential lines that cluster around particular values of oxygen fugacity and water activity for similar datasets. The changes in chemical composition of proteomes are likely linked with reactions among other cellular molecules. A redox balance calculation indicates that an increase in the lipid to protein ratio in cancer cells by 20% over hypoxic cells would generate a large enough electron sink for oxidation of the cancer proteomes. The datasets and computer code used here are made available in a new R package, canprot.Entities:
Keywords: Compositional biology; Redox balance; Thermodynamic potential
Year: 2017 PMID: 28603672 PMCID: PMC5463988 DOI: 10.7717/peerj.3421
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Selected proteomic datasets for colorectal cancer.
Here and in Tables 2–4, n1 and n2 stand for the numbers of down- and up-expressed proteins, respectively, in each dataset.
| Set | Description | Set | Description | ||||
|---|---|---|---|---|---|---|---|
| ΩaAⒶ | 57 | 70 | T/N | ΩsAⒶ | 73 | 175 | MSS-type T/N |
| ΩbAⒶ | 101 | 28 | CRC C/A | ΩtAⒶ | 79 | 677 | T/N |
| ΩcAⒶ | 87 | 81 | CIN C/A | ΩuAⒶ | 55 | 68 | CM T/N |
| ΩdAⒶ | 157 | 76 | MIN C/A | ΩvAⒶ | 33 | 37 | stromal T/N |
| ΩeAⒶ | 43 | 56 | biomarkers up/down | ΩwAⒶ | 51 | 55 | chromatin-binding C/A |
| ΩfAⒶ | 48 | 166 | stage I/normal | ΩxAⒶ | 58 | 65 | epithelial A/N |
| ΩgAⒶ | 77 | 321 | stage II/normal | ΩyAⒶ | 44 | 210 | tissue secretome T/N |
| ΩhAⒶ | 61 | 57 | microdissected T/N | ΩzAⒶ | 113 | 66 | membrane enriched T/N |
| ΩiAⒶ | 71 | 92 | adenoma/normal | ΩAAⒶ | 1061 | 1254 | A/N |
| ΩjAⒶ | 109 | 72 | stage I/normal | ΩBAⒶ | 772 | 1007 | C/A |
| ΩkAⒶ | 164 | 140 | stage II/normal | ΩCAⒶ | 879 | 1281 | C/N |
| ΩlAⒶ | 63 | 131 | stage III/normal | ΩDAⒶ | 123 | 75 | stromal AD/NC |
| ΩmAⒶ | 42 | 26 | stage IV/normal | ΩEAⒶ | 125 | 60 | stromal CIS/NC |
| ΩnAⒶ | 72 | 45 | T/N | ΩFAⒶ | 99 | 75 | stromal ICC/NC |
| ΩoAⒶ | 335 | 288 | A/N | ΩGAⒶ | 191 | 178 | biopsy T/N |
| ΩpAⒶ | 373 | 257 | C/A | ΩHAⒶ | 113 | 86 | AD/NC |
| ΩqAⒶ | 351 | 232 | C/N | ΩIAⒶ | 169 | 138 | CIS/NC |
| ΩrAⒶ | 75 | 61 | poor/good prognosis | ΩJAⒶ | 129 | 100 | ICC/NC |
Notes.
tumor
normal
carcinoma or adenocarcinoma
adenoma
conditioned media
adenomatous colon polyps
carcinoma in situ
invasive colonic carcinoma
non-neoplastic colonic mucosa
ΩaAⒶ Source: Table 1 and Suppl. Data 1 of Watanabe et al. (2008). ΩbAⒶΩcAⒶΩdAⒶ Nuclear matrix proteome; chromosomal instability (CIN), microsatellite instability (MIN), or both types (CRC). Source: Suppl. Tables 5–7 of Albrethsen et al. (2010). ΩeAⒶ Candidate serum biomarkers. Source: Table 4 of Jimenez et al. (2010). ΩfAⒶ ΩgAⒶ Source: Suppl. Table 4 of Xie et al. (2010). ΩhAⒶ Source: Suppl. Table 4 of Zhang et al. (2010). ΩiAⒶΩjAⒶΩkAⒶΩlAⒶΩmAⒶ Source: Suppl. Table 9 of Besson et al. (2011). ΩnAⒶ Source: Suppl. Table 2 of Jankova et al. (2011). ΩoAⒶ ΩpAⒶ ΩqAⒶ Source: Table S8 of Mikula et al. (2011). ΩrAⒶ Source: extracted from Suppl. Table 5 of Kim et al. (2012), including proteins with abundance ratio >2 or <0.5. ΩsAⒶ Microsatellite stable (MSS) type CRC tissue. Source: Suppl. Table 4 of Kang et al. (2012). ΩtAⒶ Source: Suppl. Table 4 of Wiśniewski et al. (2012). ΩuAⒶ Source: Suppl. Table 2 of Yao et al. (2012). ΩvAⒶ Source: Table 1 of Mu et al. (2013). ΩwAⒶ Source: Table 2 of Knol et al. (2014). ΩxAⒶ Source: Table III of Uzozie et al. (2014). ΩyAⒶ Source: Suppl. Table 1 of de Wit et al. (2014). ΩzAⒶ Source: Supporting Table 2 of Sethi et al. (2015). ΩAAⒶΩBAⒶΩCAⒶ Source: SI Table 3 of Wiśniewski et al. (2015). ΩDAⒶ ΩEAⒶ ΩFAⒶ Source: Suppl. Table S3 of Li et al. (2016). ΩGAⒶ Source: extracted from SI Table S3 of Liu et al. (2016), including proteins with p-value < 0.05. ΩHAⒶΩIAⒶΩJAⒶ Source: Suppl. Table 4 of Peng et al. (2016).
Gene names or GI numbers were converted to UniProt IDs using the UniProt mapping tool.
IPI numbers were converted to UniProt IDs using the DAVID conversion tool.
Selected proteomic datasets for hyperosmotic stress experiments.
| Set | Description | Set | Description | ||||
|---|---|---|---|---|---|---|---|
| ΩaAⒶ | 38 | 44 | ΩnAⒶ | 49 | 28 | eel gill | |
| ΩbAⒶ | 33 | 62 | ΩoAⒶ | 78 | 77 | ||
| ΩcAⒶ | 18 | 65 | ΩpAⒶ | 67 | 67 | ||
| ΩdAⒶ | 63 | 94 | mouse pancreatic islets | ΩqAⒶ | 87 | 87 | |
| ΩeAⒶ | 148 | 44 | adipose-derived stem cells | ΩrAⒶ | 25 | 38 | IOBA-NHC |
| ΩfAⒶ | 17 | 11 | ARPE-19 25 mM | ΩsAⒶ | 105 | 96 | CAUCR succinate tr. |
| ΩgAⒶ | 21 | 24 | ARPE-19 100 mM | ΩtAⒶ | 209 | 142 | CAUCR NaCl tr. |
| ΩhAⒶ | 114 | 61 | ECO57 25 °C, | ΩuAⒶ | 33 | 33 | CAUCR succinate pr. |
| ΩiAⒶ | 238 | 61 | ECO57 14 °C, | ΩvAⒶ | 33 | 27 | CAUCR NaCl pr. |
| ΩjAⒶ | 263 | 56 | ECO57 25 °C, | ΩwAⒶ | 294 | 205 | CHO all |
| ΩkAⒶ | 372 | 73 | ECO57 14 °C, | ΩxAⒶ | 66 | 75 | CHO high |
| ΩlAⒶ | 32 | 39 | Chang liver cells 25 mM | ΩyAⒶ | 14 | 28 | |
| ΩmAⒶ | 19 | 50 | Chang liver cells 100 mM | ΩzAⒶ | 160 | 141 |
Notes.
very high glucose
human retinal pigmented epithelium cells
Escherichia coli O157:H7 Sakai
human conjunctival epithelial cells
Caulobacter crescentus
transcriptome
proteome
Chinese hamster ovary cells
ΩaAⒶΩbAⒶΩcAⒶ VHG (300 g/L) vs control (20 g/L). The comparisons here use proteins with expression ratios <0.9 or >1.1 and with p-values < 0.05. Source: SI Table of Pham & Wright (2008). ΩdAⒶ 24 h at 16.7 mM vs 5.6 mM glucose. Source: extracted from Suppl. Table ST4 of Waanders et al. (2009); including the red- and blue-highlighted rows in the source table (those with ANOVA p-value < 0.01), and applying the authors’ criterion that proteins be identified by 2 or more unique peptides in at least 4 of the 8 most intense LC-MS/MS runs. ΩeAⒶ 300 mOsm (control) or 400 mOsm (NaCl treatment). Source: Suppl. Table 1 of Oswald et al. (2011). ΩfAⒶ ΩgAⒶ Mannitol-balanced 5.5 (control), 25 or 100 mM d-glucose media. Source: Table 1 of Chen et al. (2012). ΩhAⒶ ΩiAⒶ ΩjAⒶ ΩkAⒶ Temperature and NaCl treatment (control: 35 °C, aw 0.993). Source: Suppl. Tables S13–S16 of Kocharunchitt et al. (2012). ΩlAⒶ ΩmAⒶ 5.5 (control), 25 or 100 mM d-glucose. Source: Table 1 of Chen et al. (2013). ΩnAⒶ Gill proteome of Japanese eel (Anguilla japonica) adapted to seawater or freshwater. Source: protein IDs from Suppl. Table 3 and gene names of human orthologs from Suppl. File 4 of Tse et al. (2013). ΩoAⒶ ΩpAⒶΩqAⒶ Multiple experiments for 30 min after transfer from YPKG (0.5% glucose) to YNB (2% glucose) media. Source: extracted from Suppl. Files 3 and 5 of Giardina, Stanley & Chiang (2014), using the authors’ criterion of p-value < 0.05. ΩrAⒶ 280 (control), 380, or 480 mOsm (NaCl treatment) for 24 h. Source: Table 2 of Chen et al. (2015). ΩsAⒶΩtAⒶΩuAⒶΩvAⒶ Overnight treatment with a final concentration of 40/50 mM NaCl or 200 mM sucrose vs M2 minimal salts medium plus glucose (control). Source: Table S2 of Kohler et al. (2015). ΩwAⒶ ΩxAⒶ 15 g/L vs 5 g/L (control) glucose at days 0, 3, 6, and 9. The comparisons here use all proteins reported to have expression patterns in Cluster 1 (up) or Cluster 5 (down), or only the proteins with high expression differences (ratio ≤ − 0.2 or ≥0.2) at all time points. Source: SI Table S4 of Liu et al. (2015). ΩyAⒶ 4.21 osmol/kg vs 3.17 osmol/kg osmotic pressure (NaCl treatment). Source: Table 1 of Yang et al. (2015). ΩzAⒶ 0.1 M KCl (treatment) vs medium with no added KCl (control). Source: Suppl. Tables 2 and 3 of da Silva Rodrigues et al. (2016).
Gene names, GI numbers, or NCBI RefSeq accessions were converted to UniProt IDs using the UniProt mapping tool.
Amino acid sequences were obtained for the listed GI numbers using Batch Entrez (https://www.ncbi.nlm.nih.gov/sites/batchentrez).
Selected proteomic datasets for pancreatic cancer.
| Set | Description | Set | Description | ||||
|---|---|---|---|---|---|---|---|
| ΩaAⒶ | 41 | 69 | T/N | ΩlAⒶ | 29 | 73 | FFPE PC/AIP |
| ΩbAⒶ | 60 | 88 | T/N | ΩmAⒶ | 53 | 73 | FFPE PC/CP |
| ΩcAⒶ | 48 | 54 | T/N | ΩnAⒶ | 83 | 32 | low-grade T/N |
| ΩdAⒶ | 19 | 95 | CP/N | ΩoAⒶ | 224 | 176 | high-grade T/N |
| ΩeAⒶ | 28 | 29 | T/N | ΩpAⒶ | 208 | 219 | T/N (no DM) |
| ΩfAⒶ | 38 | 45 | T/N | ΩqAⒶ | 56 | 167 | T/N (DM) |
| ΩgAⒶ | 207 | 152 | FFPE T/N | ΩrAⒶ | 227 | 148 | LCM PDAC/ANT |
| ΩhAⒶ | 108 | 86 | accessible T/N | ΩsAⒶ | 65 | 34 | T/N |
| ΩiAⒶ | 38 | 47 | FFPE T/N | ΩtAⒶ | 35 | 51 | mouse 2.5 w T/N |
| ΩjAⒶ | 78 | 57 | T/N | ΩuAⒶ | 40 | 73 | mouse 3.5 w T/N |
| ΩkAⒶ | 257 | 456 | T/N | ΩvAⒶ | 49 | 84 | mouse 5 w T/N |
| ΩwAⒶ | 37 | 108 | mouse 10 w T/N |
Notes.
tumor
normal
chronic pancreatitis
autoimmune pancreatitis
pancreatic cancer
diabetes mellitus
pancreatic ductal adenocarcinoma
adjacent normal tissue
formalin-fixed paraffin-embedded
laser-capture microdissection
normal pancreas
ΩaAⒶ Pooled tissue samples of PC and matched normal tissue from 12 patients. Source: Tables 2 and 3 of Lu et al. (2004). ΩbAⒶ Two PC and two NP samples. Source: Tables 1 and 2 of Chen et al. (2005). ΩcAⒶ Large-scale immunoblotting (PowerBlot) of 8 tissue specimens of pancreatic intraepithelial neoplasia compared to NP and CP. Source: Table 2 of Crnogorac-Jurcevic et al. (2005). ΩdAⒶ Tissue specimens from patients with CP and 10 control specimens from patients with NP. Source: Table 1 of Chen et al. (2007). ΩeAⒶ 12 carcinoma samples (PDAC), 12 benign pancreatic cystadenomas and 10 normal tissues adjacent to the PDAC primary mass. Source: Table 1 of Cui et al. (2009). ΩfAⒶ Source: extracted from Table S2 of McKinney et al. (2011). ΩgAⒶ PDAC compared to NP. Source: Suppl. Table 3 of Pan et al. (2011). ΩhAⒶ Potentially accessible proteins in fresh samples of PC tumors (three patients) vs normal tissue (two patients with NP and one with CP). Source: extracted from the SI Table of Turtoi et al. (2011). ΩiAⒶ 11 tissue specimens containing >50% cancer and 8 unmatched, uninvolved tissues adjacent to pancreatitis. Source: Suppl. Tables 2 and 3 of Kojima et al. (2012). ΩjAⒶ Fresh-frozen PDAC tissue specimens from seven patients vs a pooled mixture of three normal main pancreatic duct tissue samples. Source: extracted from SI Table S3 of Kawahara et al. (2013), including proteins with an expression ratio >2 [or <0.5] in at least five of the seven experiments and ratio >1 [or <1] in all experiments. ΩkAⒶ Frozen samples of PDAC tumors vs adjacent benign tissue from four patients. Source: Suppl. Table 2 of Kosanam et al. (2013). ΩlAⒶΩmAⒶ Tissue samples from three patients with PC vs 3 patients with AIP or three patients with CP. Source: extracted from Tables 2, 3, and 4 of Paulo et al. (2013). ΩnAⒶ ΩoAⒶ 12 samples each (pooled) of low-grade tumor or high-grade tumor vs non-tumor. Source: extracted from Suppl. Tables S4 and S5 of Wang et al. (2013b), including proteins with ratios ≥3/2 or ≤2/3 for at least two of the four groups, and with expression differences for all four groups in the same direction. ΩpAⒶΩqAⒶ Source: extracted from Suppl. Tables S3 and S4 of Wang et al. (2013a), including proteins with >3/2 or <2/3 fold change in at least 3 of 4 iTRAQ experiments for different pooled samples. ΩrAⒶ LCM of CD24+ cells from PDAC vs CD24− cells from adjacent normal tissue (ANT). Source: SI Table S5 of Zhu et al. (2013). ΩsAⒶ Matched PDAC and normal tissue from nine patients. Source: extracted from SI Table S5 of Iuga et al. (2014), excluding “not passed” proteins (those with inconsistent regulation). ΩtAⒶΩuAⒶΩvAⒶΩwAⒶ PDAC tumors in transgenic mice vs pancreas in normal mice, at time points of 2.5, 3.5, 5 and 10 weeks. Source: Suppl. Table of Kuo et al. (2016).
Gene names, IPI numbers or UniProt names were converted to UniProt IDs using the UniProt mapping tool.
IPI numbers were converted to UniProt IDs using the DAVID conversion tool.
Includes differentially expressed proteins shared between groups and proteins identified in only one group.
Figure 1Compositional analysis of differential protein expression in (A) colorectal cancer and (B) pancreatic cancer.
The plots show differences (Δ) between the mean for up-expressed and the mean for down-expressed proteins of average oxidation state of carbon (ZC) and water demand per residue () for each dataset from Tables 1 and 2. Red colors highlight (A) adenoma/normal comparisons or (B) chronic pancreatitis/normal or low-grade tumor/normal comparisons. Here and in Fig. 2, filled points and dashed lines indicate p < 0.05; solid lines are drawn instead if the common language effect size is ≥60% or ≤40%.
Figure 2Compositional analysis of differential protein expression in (A) hypoxia or 3D culture and (B) hyperosmotic stress.
The plots show differences (Δ) between the mean for up-expressed and the mean for down-expressed proteins of average oxidation state of carbon (ZC) and water demand per residue () for each dataset from Tables 3 and 4. Red, blue, and orange symbols are used to highlight datasets for tumorspheres, reoxygenation or anti-hypoxic treatment, and adipose-derived stem cells, respectively.
Selected proteomic datasets for hypoxia and reoxygenation experiments or growth in 3D culture.
| Set | Description | Set | Description | Set | Description | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ΩaAⒶ | 37 | 24 | U937 | ΩkAⒶ | 56 | 40 | THP-1 | ΩvAⒶ | 113 | 154 | CRC-derived SPH |
| ΩbAⒶ | 41 | 22 | placental secretome | ΩlAⒶ | 178 | 77 | A431 Hx48 | ΩwAⒶ | 127 | 292 | HepG2/C3A SPH |
| ΩcAⒶ | 71 | 19 | B104 | ΩmAⒶ | 69 | 54 | A431 Hx72 | ΩxAⒶ | 53 | 72 | HeLa |
| ΩdAⒶ | 87 | 28 | DU145 | ΩnAⒶ | 48 | 36 | A431 ReOx | ΩyAⒶ | 137 | 64 | U87MG and 786-O |
| ΩeAⒶ | 29 | 21 | SK-N-BE(2)c; IMR-32 | ΩoAⒶ | 141 | 64 | SH-SY5Y | ΩzAⒶ | 129 | 141 | HCT116 transcription |
| ΩfAⒶ | 53 | 65 | H9C2 | ΩpAⒶ | 65 | 34 | A431 Hx48-S | ΩAAⒶ | 469 | 1024 | HCT116 translation |
| ΩgAⒶ | 409 | 337 | MCF-7 SPH P5 | ΩqAⒶ | 137 | 61 | A431 Hx72-S | ΩBAⒶ | 66 | 50 | adipose-derived SC |
| ΩhAⒶ | 248 | 214 | MCF-7 SPH P2 | ΩrAⒶ | 56 | 49 | A431 ReOx-S | ΩCAⒶ | 65 | 27 | cardiomyocytes CoCl2 |
| ΩiAⒶ | 48 | 52 | SPH perinecrotic | ΩsAⒶ | 74 | 44 | A431 Hx48-P | ΩDAⒶ | 35 | 69 | cardiomyocytes SAL |
| ΩjAⒶ | 101 | 186 | SPH necrotic | ΩtAⒶ | 67 | 53 | A431 Hx72-P | ΩEAⒶ | 116 | 225 | HT29 SPH |
| ΩuAⒶ | 41 | 31 | A431 ReOx-P |
Notes.
acute promonocytic leukemic cells
rat neuroblastoma cells
prostate carcinoma cells
neuroblastoma cells
rat heart myoblast
breast cancer cells
macrophages
epithelial carcinoma cells
hypoxia 48 h
hypoxia 72 h
hypoxia 48 h followed by reoxygenation for 24 h
supernatant fraction
pellet fraction
spheroids
hepatocellular carcinoma cells
glioblastoma
renal clear cell carcinoma cells
colon cancer cells
stem cells
salidroside
ΩaAⒶ 2% O2 vs normoxic conditions. Source: Table 1 of Han et al. (2006). ΩbAⒶ 1% vs 6% O2. Source: Tables 2 and 3 of Blankley et al. (2010). ΩcAⒶ Expression ratios HYP/LSC (oxygen deprivation/low serum control) >1.2 or <0.83. Source: calculated using data from Suppl. Table 2 of Datta et al. (2010), including proteins with p-value < 0.05 and EF < 1.4. ΩdAⒶ Translationally regulated genes. Source: Suppl. Tables 1–4 of van den Beucken et al. (2011). ΩeAⒶ 1% O2 for 72 h vs standard conditions. Source: Suppl. Table 1(a) of Cifani et al. (2011). ΩfAⒶ Hypoxic vs control conditions for 16 h. Source: Suppl. Table S5 of Li et al. (2012). ΩgAⒶ ΩhAⒶ Tumorspheres (50 to 200 μm diameter) at passage 5 (P5) or 2 (P2) compared to adherent cells. Source: Sheets 2 and 3 in Table S1 of Morrison et al. (2012). ΩiAⒶ ΩjAⒶ Perinecrotic and necrotic regions compared to surface of multicell spheroids (∼600 μm diameter) (expression ratios <0.77 or >1.3). Source: Suppl. Table 1C of McMahon et al. (2012). ΩkAⒶ Incubation for several days under hypoxia (1% O2). Source: Suppl. Table 2A of Fuhrmann et al. (2013) (control virus cells). ΩlAⒶΩmAⒶΩnAⒶ Source: extracted from Suppl. Table 1 of Ren et al. (2013), including proteins with iTRAQ ratios <0.83 or >1.2 and p-value < 0.05. ΩoAⒶ 5% O2 vs atmospheric levels of O2 (normalized expression ratio >1.2 or <0.83). Source: SI table of Villeneuve et al. (2013). ΩpAⒶΩqAⒶΩrAⒶΩsAⒶΩtAⒶΩuAⒶ The comparisons here include proteins with p < 0.05. Source: Suppl. Table S1 of Dutta et al. (2014). ΩvAⒶ Organotypic spheroids (∼250 μm diameter) vs lysed CRC tissue. Source: extracted from Table S2 of Rajcevic et al. (2014), filtered as follows: at least two of three experiments have differences in spectral counts, absolute overall fold change is at least 1.5, and p-value is less than 0.05. ΩwAⒶ SPH vs classical cell culture (2D growth) (log2 fold change at least ±1). Source: P1_Data sheet in the SI of Wrzesinski et al. (2014). ΩxAⒶ 1% vs 19% O2. Source: Table S1 of Bousquet et al. (2015). ΩyAⒶ 1% O2 for 24 h (fold change <0.5 or >1 for proteins detected in only hypoxic or only normoxic conditions). Source: Table S1 of Ho et al. (2016). ΩzAⒶΩAAⒶ Microarray analysis of differential gene expression in the transcriptome (total rRNA) and translatome (polysomal/total RNA ratio) of cells grown in normal and hypoxic (1% O2) conditions. Source: data file supplied by Ming-Chih Lai (Lai, Chang & Sun, 2016). ΩBAⒶ ASC from three donors cultured for 24 h in hypoxic (1% O2) vs normoxic (20% O2) conditions. Source: Tables 1 and 2 of Riis et al. (2016). ΩCAⒶ ΩDAⒶ Rat cardiomyocytes treated with CoCl2 (hypoxia mimetic) vs control or with SAL (anti-hypoxic) vs CoCl2. Source: SI Tables 1S and 2S of Xu et al. (2016). ΩEAⒶ 800 μm spheroids vs 2D monolayers. Source: Tables S1a–b of Yue et al. (2016).
Gene names, GI numbers, or other IDs were converted to UniProt IDs using the UniProt mapping tool.
IPI numbers were converted to UniProt IDs using the DAVID conversion tool.
Figure 3Merged potential diagrams for proteomic transformations.
Plots are shown for (A) 13 datasets for colorectal cancer and (B) 11 datasets for pancreatic cancer with ΔZC > 0.01, (C) eight datasets for hypoxia or 3D culture with ΔZC < − 0.01, (D) 10 datasets for colorectal cancer and (E) eight datasets for pancreatic cancer with , and (F) 12 datasets for hyperosmotic stress with . Red and blue colors denote higher relative potential for formation of up- and down-expressed proteins, respectively. White lines are equipotential lines, where the mean weighted rank difference of affinity (WRD; Eq. (3)) of the included datasets is 0; black lines show the median and interquartile range of the WRD = 0 lines for individual datasets (Fig. S3). See text for details.
Figure 4A computer-aided “back of the envelope” calculation to estimate the lipid to protein ratio (L:P) in cancer cells and the percent difference from normal cells in hypoxic conditions.
Bold text indicates function definitions (R code) or numerical results (comments/results (rounded)). Numerical values are taken from [1] the chemical formula of 1-palmitoyl-2,3-dioleoyl-glycerol, given as an example of a triacylglycerol (triglyceride) in the chapter on lipid metabolism in Voet, Voet & Pratt (2013), [2] the average chemical formula of proteins in the UniProt human proteome, for which amino acid compositions are stored in human_base.Rdata in the canprot package, [3] this study, and [4] Table 2 of Gordon, Barcza & Bush (1977) (mouse cells grown in hypoxic conditions).